Institutional shares held 45.4 Million
272K calls
30.8K puts
Total value of holdings $277M
$1.66M calls
$187K puts
Market Cap $289M
45,010,700 Shares Out.
Institutional ownership 100.82%
# of Institutions 102


Latest Institutional Activity in MGTX

Top Purchases

Q4 2024
Woodline Partners LP Shares Held: 1.54M ($9.84M)
Q4 2024
Long Focus Capital Management, LLC Shares Held: 190K ($1.22M)
Q4 2024
Readystate Asset Management LP Shares Held: 119K ($762K)
Q4 2024
Ubs Group Ag Shares Held: 119K ($766K)
Q4 2024
Knott David M Jr Shares Held: 95.1K ($609K)

Top Sells

Q4 2024
Prosight Management, LP Shares Held: 4.39M ($28.1M)
Q4 2024
J. Goldman & CO LP Shares Held: 551K ($3.53M)
Q4 2024
Adage Capital Partners Gp, L.L.C. Shares Held: 5.03M ($32.3M)
Q4 2024
Royce & Associates LP Shares Held: 610K ($3.91M)
Q4 2024
683 Capital Management, LLC Shares Held: 2.42M ($15.5M)

About MGTX

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative diseases, such as amyotrophic lateral sclerosis; and Parkinson's diseases. Its programs in clinical development include Phase 1/2 clinical stage programs in Achromatopsia, X-Linked Retinitis Pigmentosa, RPE65-deficiency, and radiation-induced Xerostomia, as well as Parkinson's program. The company also focuses on initiating a clinical program in xerostomia related to Sjogren's syndrome and have preclinical programs in neurodegenerative diseases. It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. to develop regulatable gene therapy treatment using the company's proprietary riboswitch technology. MeiraGTx Holdings plc was incorporated in 2015 and is based in New York, New York.


Insider Transactions at MGTX

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
1.93M Shares
From 8 Insiders
Open market or private purchase 1.25M shares
Exercise of conversion of derivative security 681K shares
Sell / Disposition
394K Shares
From 9 Insiders
Payment of exercise price or tax liability 319K shares
Bona fide gift 4K shares
Open market or private sale 71.5K shares

Track Institutional and Insider Activities on MGTX

Follow MeiraGTx Holdings plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MGTX shares.

Notify only if

Insider Trading

Get notified when an Meira G Tx Holdings PLC insider buys or sells MGTX shares.

Notify only if

News

Receive news related to MeiraGTx Holdings plc

Track Activities on MGTX